Federal Trade Commission - Home Page
Competition in the Health Care Marketplace
  Images respresenting health care
 
Overview
Competition News
Antitrust Actions
Industry Guidance
Research, Hearings & Reports
Pharmaceutical Agreement Filings
Advocacy & Outreach
Speeches & Testimony
Consumer Information
Hearings
 

July 2004 Health Care Report and Executive Summary and Press Release


 Overview

The Federal Trade Commission and Department of Justice will commence public hearings in Washington, D.C. on February 26, 2003 on the implications of competition law and policy for health care financing and delivery. The hearings will broadly consider the impact of competition law and policy on the cost, quality, and availability of health care, and the incentives for innovation in the field.

Specific subjects to be considered include hospital mergers, the significance of non-profit status, vertical integration, quality and efficiencies, the boundaries of the state action and Noerr-Pennington doctrines, monopsony power, the adequacy of existing remedies for anticompetitive conduct, and the implications of the Commission's consumer protection mandate with regard to the performance of the health care financing and delivery markets.

The goal is to promote dialogue, learning, and consensus building among all interested parties. The FTC and the DOJ plan to hold three to five days of hearings per month between March and September 2003, exclusive of August 2003.

[Back to Top]

  Agenda

[Back to Top]

 Materials

  • Transcripts
    • October 2003
      • 1st [PDF 188KB]

    • September 2003
    • June 2003
    • March 2003
    • February 2003

[Back to Top]

 Press Releases and Federal Register Notice

[Back to Top]

 Links and Contact Information

[Back to Top]

For more information, contact: David Hyman, Special Counsel, 202-326-2622 (dhyman@ftc.gov)

 

Last Updated: Wednesday, July 8, 2009 12:58 PM